45 CFR § 180 compliance
A · 100
This hospital published most of what § 180 requires.
●Machine-readable file published: assessment threshold met
●Gross / standard charges: assessment threshold met
●Discounted cash price: assessment threshold met
●Payer-specific negotiated rates: assessment threshold met
●Min / max negotiated charges: assessment threshold met
●Free, public, no login required: assessment threshold met
Procedures listed
7,515
Insurances with rates
13
CPT / HCPCS codes
6,384
Most expensive procedures (gross)
J0225
$489,339
VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE
Gross
$596,755
J0225
$489,339
VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE
Gross
$596,755
J7330
$286,065
AUTOL CHONDROCYTE-COLLAGPORC 500000 CELL/CM2 (3 X 5 CM)IMPLANT SHEET
Gross
$348,860
J7330
$286,065
AUTOL CHONDROCYTE-COLLAGPORC 500000 CELL/CM2 (3 X 5 CM)IMPLANT SHEET
Gross
$348,860
J1823
$197,998
INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION
Gross
$241,461
J1823
$197,998
INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION
Gross
$241,461
A9513
$194,750
LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION
Gross
$237,500
A9513
$194,750
LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION
Gross
$237,500
J2351
$178,057
OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23000 UNIT/23 ML SUBCUT SOLN
Gross
$217,143
J2351
$178,057
OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23000 UNIT/23 ML SUBCUT SOLN
Gross
$217,143
C9293
$177,255
GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION
Gross
$216,165
C9293
$177,255
GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION
Gross
$216,165
J9999
$173,184
CARMUSTINE IN POLIFEPROSAN 7.7 MG WAFER FOR IMPLANT
Gross
$211,200
J9999
$173,184
CARMUSTINE IN POLIFEPROSAN 7.7 MG WAFER FOR IMPLANT
Gross
$211,200
J9228
$151,467
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$184,716
J9228
$151,467
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$184,716
J9350
$118,673
MOSUNETUZUMAB-AXGB 45 MG/ML SUBCUTANEOUS SOLUTION
Gross
$144,723
J9350
$118,673
MOSUNETUZUMAB-AXGB 45 MG/ML SUBCUTANEOUS SOLUTION
Gross
$144,723
J1747
$114,403
SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION
Gross
$139,516
J1747
$114,403
SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION
Gross
$139,516
J2327
$94,317
RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE
Gross
$115,020
J2327
$94,317
RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE
Gross
$115,020
J0638
$91,606
CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION
Gross
$111,715
J0638
$91,606
CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION
Gross
$111,715
J2350
$88,717
OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION
Gross
$108,191
J2350
$88,717
OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION
Gross
$108,191
J9309
$80,602
POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION
Gross
$98,295
J9309
$80,602
POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION
Gross
$98,295
J9321
$68,680
EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION
Gross
$83,756
J9321
$68,680
EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION
Gross
$83,756
J9334
$67,282
EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11200 UNIT/5.6 ML SUBCUT SOLN
Gross
$82,051
J9334
$67,282
EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11200 UNIT/5.6 ML SUBCUT SOLN
Gross
$82,051
J9298
$64,269
NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION
Gross
$78,377
J9298
$64,269
NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION
Gross
$78,377
J2507
$63,083
PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION
Gross
$76,930
J2507
$63,083
PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION
Gross
$76,930
J3357
$62,529
USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION
Gross
$76,255
J3357
$62,529
USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION
Gross
$76,255
J9345
$61,440
RETIFANLIMAB-DLWR 500 MG/20 ML INTRAVENOUS SOLUTION
Gross
$74,927
J9345
$61,440
RETIFANLIMAB-DLWR 500 MG/20 ML INTRAVENOUS SOLUTION
Gross
$74,927
J1628
$60,514
GUSELKUMAB 100 MG/ML SUBCUTANEOUS SYRINGE
Gross
$73,797
J1628
$60,514
GUSELKUMAB 100 MG/ML SUBCUTANEOUS SYRINGE
Gross
$73,797
J9316
$59,417
PERTUZUMAB 1200 MG-TRASTUZUMAB 600 MG-HYALURON-ZZXF/15 ML SUBCUT SOLN
Gross
$72,459
J9316
$59,417
PERTUZUMAB 1200 MG-TRASTUZUMAB 600 MG-HYALURON-ZZXF/15 ML SUBCUT SOLN
Gross
$72,459
J9042
$53,809
BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION
Gross
$65,620
J9042
$53,809
BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION
Gross
$65,620
J9277
$50,139
PEMBROLIZUMAB 395 MG-BERAHYALURONID-PMPH 4800 UNIT/2.4 ML SUBCUT SOLN
Gross
$61,145
J9277
$50,139
PEMBROLIZUMAB 395 MG-BERAHYALURONID-PMPH 4800 UNIT/2.4 ML SUBCUT SOLN
Gross
$61,145
J9272
$50,135
DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION
Gross
$61,140
J9272
$50,135
DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION
Gross
$61,140
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J0225 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $596,755 | $489,339 | $413,850 | $572,885 | 16 |
| J0225 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $596,755 | $489,339 | $127,825 | $572,885 | 32 |
| J7330 | AUTOL CHONDROCYTE-COLLAGPORC 500000 CELL/CM2 (3 X 5 CM)IMPLANT SHEET | $348,860 | $286,065 | $241,934 | $334,906 | 16 |
| J7330 | AUTOL CHONDROCYTE-COLLAGPORC 500000 CELL/CM2 (3 X 5 CM)IMPLANT SHEET | $348,860 | $286,065 | $74,726 | $334,906 | 32 |
| J1823 | INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION | $241,461 | $197,998 | $167,453 | $231,803 | 16 |
| J1823 | INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION | $241,461 | $197,998 | $51,721 | $231,803 | 32 |
| A9513 | LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION | $237,500 | $194,750 | $164,706 | $228,000 | 16 |
| A9513 | LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION | $237,500 | $194,750 | $50,873 | $228,000 | 32 |
| J2351 | OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23000 UNIT/23 ML SUBCUT SOLN | $217,143 | $178,057 | $150,589 | $208,457 | 16 |
| J2351 | OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23000 UNIT/23 ML SUBCUT SOLN | $217,143 | $178,057 | $46,512 | $208,457 | 32 |
| C9293 | GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION | $216,165 | $177,255 | $149,910 | $207,518 | 16 |
| C9293 | GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION | $216,165 | $177,255 | $46,303 | $207,518 | 32 |
| J9999 | CARMUSTINE IN POLIFEPROSAN 7.7 MG WAFER FOR IMPLANT | $211,200 | $173,184 | $146,467 | $202,752 | 16 |
| J9999 | CARMUSTINE IN POLIFEPROSAN 7.7 MG WAFER FOR IMPLANT | $211,200 | $173,184 | $45,239 | $202,752 | 32 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $184,716 | $151,467 | $128,101 | $177,328 | 16 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $184,716 | $151,467 | $39,566 | $177,328 | 32 |
| J9350 | MOSUNETUZUMAB-AXGB 45 MG/ML SUBCUTANEOUS SOLUTION | $144,723 | $118,673 | $100,366 | $138,935 | 16 |
| J9350 | MOSUNETUZUMAB-AXGB 45 MG/ML SUBCUTANEOUS SOLUTION | $144,723 | $118,673 | $31,000 | $138,935 | 32 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $139,516 | $114,403 | $96,755 | $133,936 | 16 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $139,516 | $114,403 | $29,884 | $133,936 | 32 |
| J2327 | RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE | $115,020 | $94,317 | $79,767 | $110,420 | 16 |
| J2327 | RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE | $115,020 | $94,317 | $24,637 | $110,420 | 32 |
| J0638 | CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION | $111,715 | $91,606 | $77,474 | $107,246 | 16 |
| J0638 | CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION | $111,715 | $91,606 | $23,929 | $107,246 | 32 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $108,191 | $88,717 | $75,031 | $103,864 | 16 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $108,191 | $88,717 | $23,175 | $103,864 | 32 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION | $98,295 | $80,602 | $68,168 | $94,363 | 16 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION | $98,295 | $80,602 | $21,055 | $94,363 | 32 |
| J9321 | EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION | $83,756 | $68,680 | $58,085 | $80,405 | 16 |
| J9321 | EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION | $83,756 | $68,680 | $17,940 | $80,405 | 32 |
| J9334 | EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11200 UNIT/5.6 ML SUBCUT SOLN | $82,051 | $67,282 | $56,902 | $78,769 | 16 |
| J9334 | EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11200 UNIT/5.6 ML SUBCUT SOLN | $82,051 | $67,282 | $17,575 | $78,769 | 32 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $78,377 | $64,269 | $54,354 | $75,242 | 16 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $78,377 | $64,269 | $16,788 | $75,242 | 32 |
| J2507 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $76,930 | $63,083 | $53,351 | $73,853 | 16 |
| J2507 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $76,930 | $63,083 | $16,478 | $73,853 | 32 |
| J3357 | USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION | $76,255 | $62,529 | $52,883 | $73,205 | 16 |
| J3357 | USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION | $76,255 | $62,529 | $16,334 | $73,205 | 32 |
| J9345 | RETIFANLIMAB-DLWR 500 MG/20 ML INTRAVENOUS SOLUTION | $74,927 | $61,440 | $51,962 | $71,930 | 16 |
| J9345 | RETIFANLIMAB-DLWR 500 MG/20 ML INTRAVENOUS SOLUTION | $74,927 | $61,440 | $16,049 | $71,930 | 32 |
| J1628 | GUSELKUMAB 100 MG/ML SUBCUTANEOUS SYRINGE | $73,797 | $60,514 | $51,178 | $70,845 | 16 |
| J1628 | GUSELKUMAB 100 MG/ML SUBCUTANEOUS SYRINGE | $73,797 | $60,514 | $15,807 | $70,845 | 32 |
| J9316 | PERTUZUMAB 1200 MG-TRASTUZUMAB 600 MG-HYALURON-ZZXF/15 ML SUBCUT SOLN | $72,459 | $59,417 | $50,251 | $69,561 | 16 |
| J9316 | PERTUZUMAB 1200 MG-TRASTUZUMAB 600 MG-HYALURON-ZZXF/15 ML SUBCUT SOLN | $72,459 | $59,417 | $15,521 | $69,561 | 32 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $65,620 | $53,809 | $45,508 | $62,995 | 16 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $65,620 | $53,809 | $14,056 | $62,995 | 32 |
| J9277 | PEMBROLIZUMAB 395 MG-BERAHYALURONID-PMPH 4800 UNIT/2.4 ML SUBCUT SOLN | $61,145 | $50,139 | $42,404 | $58,699 | 16 |
| J9277 | PEMBROLIZUMAB 395 MG-BERAHYALURONID-PMPH 4800 UNIT/2.4 ML SUBCUT SOLN | $61,145 | $50,139 | $13,097 | $58,699 | 32 |
| J9272 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $61,140 | $50,135 | $42,400 | $58,694 | 16 |
| J9272 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $61,140 | $50,135 | $13,096 | $58,694 | 32 |
Showing top 50 of 7,515 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.